Anti‐oncogenic Potential and Inflammation Modulatory Response of Green Synthesized Biocompatible Silver Nanoparticles
Chemistry & Biodiversity · 2024
DOI: 10.1002/cbdv.202301533 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Shobha Nagarajaiah und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Maharani's Science College for Women, Maharani Cluster University, 560 001, Bengaluru, India. Hauptthemen laut MEDLINE: Metal Nanoparticles, Breast Neoplasms, Phospholipases A2, Secretory. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 87 Literaturangaben.
Abstract (Originalsprache)
This study presents a novel approach to synthesizing silver nanoparticles (Ag NPs) using a solution combustion synthesis (SCS) method with Catharanthus roseus ( C. roseus ) leaf extract. The NPs were thoroughly characterized through X‐ray diffraction (XRD), Scanning electron microscopy (SEM), Energy dispersive X‐ray (EDX), Transmission electron microscopy (TEM), and Selected area electron diffraction (SAED), elucidating their crystal structure. Notably, the synthesized Ag NPs exhibited a significant dose‐dependent decline in viability of the MDA‐MB 231 breast cancer cell line, with an IC50 value of 13.3 μg/mL, underscoring their potential as potent anticancer agent. Beyond cytotoxicity, the study pioneers an investigation into the biocompatibility of Ag NPs by blood hemolsysis, providing critical insights into their safety and biomedical applicability. Furthermore, this research uncovers a distinctive facet of Ag NPs, revealing their inhibitory effects on the inflammatory enzyme secretory phospholipase A2 (sPLA2), a recognized biomarker for breast cancer. The demonstrated in vitro and in vivo inhibition of sPLA2 highlights the multifaceted potential of Ag NPs in not only targeting cancer cells but also modulating inflammatory responses associated with breast cancer, positioning the study at the forefront of advancements in nanomedicine and cancer therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Maharani's Science College for Women, Maharani Cluster University, 560 001, Bengaluru, India.
- Department of Biochemistry, Jain (Deemed-to-be University), School of Science, JC Road, 560 027, Bangalore, India.
- Research and Development Center, Department of Chemistry, Sir M. Visvesvaraya Institute of Technology, 562 157, Bengaluru, India.
- Department of Pharmacology, School of Medical and Allied Sciences, KR Mangalam University, 122 103, Gurgaon, India.
- Centre for Advanced Materials Technology (CAMT), M.S Ramaiah Institute of Technology, 560 054, Bengaluru, India.
- Department of Chemistry, BMS College of Engineering, 560 019, Bengaluru, India.
Zitieren
APA
Nagarajaiah, S., Shivanna Giresha, A., Gopala Krishna, P., Manikrao Gadewar, M., Praveen, M., Nanda, N., Urs, D., Krishnappa Dharmappa, K., Mutta Nagabhushana, B., Rao, S., Mahadeva Swamy, M., & Venkatesh Yatish, K. (2024). Anti‐oncogenic Potential and Inflammation Modulatory Response of Green Synthesized Biocompatible Silver Nanoparticles. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202301533
Vancouver
Nagarajaiah S, Shivanna Giresha A, Gopala Krishna P, Manikrao Gadewar M, Praveen M, Nanda N, et al. Anti‐oncogenic Potential and Inflammation Modulatory Response of Green Synthesized Biocompatible Silver Nanoparticles. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202301533
BibTeX
@article{Nagarajaiah2024,
author = {Nagarajaiah, Shobha and Shivanna Giresha, Aladahalli and Gopala Krishna, Prashanth and Manikrao Gadewar, Manoj and Praveen, Manjappa and Nanda, Nagappa and Urs, Deepadarshan and Krishnappa Dharmappa, Kattepura and Mutta Nagabhushana, Bhangi and Rao, Srilatha and Mahadeva Swamy, Mallanna and Venkatesh Yatish, Kalanakoppal},
title = {Anti‐oncogenic Potential and Inflammation Modulatory Response of Green Synthesized Biocompatible Silver Nanoparticles},
journal = {Chemistry & Biodiversity},
year = {2024},
doi = {10.1002/cbdv.202301533}
}
EUVIMED